In order to provide you with relevant and meaningful content we need to know more about you.
Please choose the category that best describes you.
This content is intended for U.S. Healthcare Professionals. Would you like to proceed?
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
Morphine Sulfate Injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Morphine Sulfate Injection is for intravenous administration.
Morphine Sulfate Injection, USP is available in the following strengths for intravenous (IV) administration.
Morphine Sulfate Injection is contraindicated in patients with:
Morphine Sulfate Injection contains morphine, a Schedule II controlled substance. As an opioid, Morphine...
The following serious adverse reactions are described, or described in greater detail, in other sections:
Table 1 includes clinically significant drug interactions with Morphine Sulfate Injection.
Prolonged use of opioid...
Morphine Sulfate Injection contains morphine, a Schedule II controlled substance.
Acute overdose with Morphine Sulfate Injection can be manifested by respiratory depression, somnolence...
Morphine Sulfate Injection, USP is an opioid agonist, available as 2 mg/mL, 4 mg/mL, 8 mg/mL, 10 mg/mL, and 15 mg/mL (1 mL fill in 1.5 mL iSecure™ Single-dose Prefilled Syringe with Luer Lock) and 2 mg/mL, 4...
Morphine is a full opioid agonist and is relatively selective for the mu-opioid receptor, although it can bind to...
Morphine Sulfate Injection, USP is supplied as a sterile solution in single-dose Carpuject™ cartridges and iSecure™ syringes for intravenous administration as follows:
Opioids can cause a rare but potentially life-threatening condition resulting from...
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if color is darker than pale...
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information. 8AM-9PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at https://vaers.hhs.gov or call (800) 822-7967.